Clinical and Imaging Outcomes after Stroke with Normal Angiograms

References

1. ↵
   del Zoppo GJ, Poeck K, Pessin MS, et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 1992;32:78–86

   CrossRefPubMedWeb of Science
2. Lewandowski CA, Frankel M, Tomsick TA, et al. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy for acute ischemic stroke: emergency management of stroke (EMS) bridging trial. Stroke 1999;30:2598–2605

   Abstract/FREE Full Text
3. ↵
   Furlan AJ, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study—a randomized controlled trial. JAMA 1999;282:2003–2011

   CrossRefPubMedWeb of Science
4. ↵
   Derex L, Tomsick TA, Brott TG, et al. EMS Bridging Trial - Outcome of stroke patients without angiographically revealed arterial occlusion within four hours of symptom onset. AJNR Am J Neuroradiol 2001;22:685–690

   Abstract/FREE Full Text
5. ↵
   del Zoppo GJ, Higashida RT, Furlan AJ, et al. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke 1998;29:4–11

   Abstract/FREE Full Text
6. ↵
   Adam HP, Bendixen BH, Kapelle LJ, et al. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. Stroke 1993;24:35–41

   Abstract/FREE Full Text
7. ↵
   Fisher CM. The arterial lesions underlying lacunes. Acta Neuropathol 1969;12:1–15
8. ↵
   Fisher CM. Capsular infarcts: the underlying vascular lesions. Arch Neurol 1979;36:65–73

   CrossRefPubMedWeb of Science